70 results
424B3
PASG
Passage Bio Inc
14 May 24
Prospectus supplement
8:15am
to invest the net proceeds from this offering in short-term or long-term, investment-grade, interest-bearing securities. These investments may … in the application of the net proceeds. Pending the uses described above, we plan to invest the net proceeds from this offering in short-term or long-term
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
-term or long-term, investment-grade, interest-bearing securities.
PLAN OF DISTRIBUTION
We may sell the securities covered by this prospectus to one … or long-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders. If we do not invest
8-K
g48p4ha
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
EX-99.2
tedt4
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.3
0s71dj9g93
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
x18aouj 31gilewriuu5
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.1
3gi6h3fdnn9f62 e8uoe
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.2
wpm pe2u2fdxo0n
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am
8-K
EX-99.2
ltwt t9sul5wjqjfu
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.2
4inp30sed6ogfos7zt
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am